COVID-19 Impact on Global Finasteride Market Insights, Forecast to 2026
Finasteride is a prescription drug in tablet form.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Finasteride market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Finasteride industry.
Based on our recent survey, we have several different scenarios about the Finasteride YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Finasteride will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Finasteride market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Finasteride market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Finasteride market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Finasteride market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Finasteride market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Finasteride market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Finasteride market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Finasteride market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Finasteride market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Finasteride industry.
Based on our recent survey, we have several different scenarios about the Finasteride YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Finasteride will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Finasteride market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Finasteride market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Finasteride market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Finasteride market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Finasteride market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Finasteride market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Finasteride market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Finasteride market.
The following manufacturers are covered in this report:
- Merck
- Actavis
- Sandoz
- Teva Pharmaceuticals
- Cipla
- RelonChem
- Dr. Reddy
- Accord Pharmaceuticals
- Henan Topfond
- Zhejiang CONBA Pharmaceutical
- Shandong Renhetang Pharmaceutical
- Guangdong Eashu Pharmacetical
- 1mg Tablet
- 5mg Tablet
- Medical Uses
- Application 2
1 STUDY COVERAGE
1.1 Finasteride Product Introduction
1.2 Market Segments
1.3 Key Finasteride Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Finasteride Market Size Growth Rate by Type
1.4.2 1mg Tablet
1.4.3 5mg Tablet
1.5 Market by Application
1.5.1 Global Finasteride Market Size Growth Rate by Application
1.5.2 Medical Uses
1.5.3 Application
1.6 Coronavirus Disease 2019 (Covid-19): Finasteride Industry Impact
1.6.1 How the Covid-19 is Affecting the Finasteride Industry
1.6.1.1 Finasteride Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Finasteride Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Finasteride Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Finasteride Market Size Estimates and Forecasts
2.1.1 Global Finasteride Revenue 2015-2026
2.1.2 Global Finasteride Sales 2015-2026
2.2 Finasteride Market Size by Region: 2020 Versus 2026
2.2.1 Global Finasteride Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Finasteride Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL FINASTERIDE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Finasteride Sales by Manufacturers
3.1.1 Finasteride Sales by Manufacturers (2015-2020)
3.1.2 Finasteride Sales Market Share by Manufacturers (2015-2020)
3.2 Finasteride Revenue by Manufacturers
3.2.1 Finasteride Revenue by Manufacturers (2015-2020)
3.2.2 Finasteride Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Finasteride Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Finasteride Revenue in 2019
3.2.5 Global Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Finasteride Price by Manufacturers
3.4 Finasteride Manufacturing Base Distribution, Product Types
3.4.1 Finasteride Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Finasteride Product Type
3.4.3 Date of International Manufacturers Enter into Finasteride Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Finasteride Market Size by Type (2015-2020)
4.1.1 Global Finasteride Sales by Type (2015-2020)
4.1.2 Global Finasteride Revenue by Type (2015-2020)
4.1.3 Finasteride Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Finasteride Market Size Forecast by Type (2021-2026)
4.2.1 Global Finasteride Sales Forecast by Type (2021-2026)
4.2.2 Global Finasteride Revenue Forecast by Type (2021-2026)
4.2.3 Finasteride Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Finasteride Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Finasteride Market Size by Application (2015-2020)
5.1.1 Global Finasteride Sales by Application (2015-2020)
5.1.2 Global Finasteride Revenue by Application (2015-2020)
5.1.3 Finasteride Price by Application (2015-2020)
5.2 Finasteride Market Size Forecast by Application (2021-2026)
5.2.1 Global Finasteride Sales Forecast by Application (2021-2026)
5.2.2 Global Finasteride Revenue Forecast by Application (2021-2026)
5.2.3 Global Finasteride Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Finasteride by Country
6.1.1 North America Finasteride Sales by Country
6.1.2 North America Finasteride Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Finasteride Market Facts & Figures by Type
6.3 North America Finasteride Market Facts & Figures by Application
7 EUROPE
7.1 Europe Finasteride by Country
7.1.1 Europe Finasteride Sales by Country
7.1.2 Europe Finasteride Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Finasteride Market Facts & Figures by Type
7.3 Europe Finasteride Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Finasteride by Region
8.1.1 Asia Pacific Finasteride Sales by Region
8.1.2 Asia Pacific Finasteride Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Finasteride Market Facts & Figures by Type
8.3 Asia Pacific Finasteride Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Finasteride by Country
9.1.1 Latin America Finasteride Sales by Country
9.1.2 Latin America Finasteride Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Finasteride Market Facts & Figures by Type
9.3 Central & South America Finasteride Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Finasteride by Country
10.1.1 Middle East and Africa Finasteride Sales by Country
10.1.2 Middle East and Africa Finasteride Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Finasteride Market Facts & Figures by Type
10.3 Middle East and Africa Finasteride Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Finasteride Products Offered
11.1.5 Merck Recent Development
11.2 Actavis
11.2.1 Actavis Corporation Information
11.2.2 Actavis Description, Business Overview and Total Revenue
11.2.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Actavis Finasteride Products Offered
11.2.5 Actavis Recent Development
11.3 Sandoz
11.3.1 Sandoz Corporation Information
11.3.2 Sandoz Description, Business Overview and Total Revenue
11.3.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sandoz Finasteride Products Offered
11.3.5 Sandoz Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Corporation Information
11.4.2 Teva Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Pharmaceuticals Finasteride Products Offered
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description, Business Overview and Total Revenue
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Finasteride Products Offered
11.5.5 Cipla Recent Development
11.6 RelonChem
11.6.1 RelonChem Corporation Information
11.6.2 RelonChem Description, Business Overview and Total Revenue
11.6.3 RelonChem Sales, Revenue and Gross Margin (2015-2020)
11.6.4 RelonChem Finasteride Products Offered
11.6.5 RelonChem Recent Development
11.7 Dr. Reddy
11.7.1 Dr. Reddy Corporation Information
11.7.2 Dr. Reddy Description, Business Overview and Total Revenue
11.7.3 Dr. Reddy Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy Finasteride Products Offered
11.7.5 Dr. Reddy Recent Development
11.8 Accord Pharmaceuticals
11.8.1 Accord Pharmaceuticals Corporation Information
11.8.2 Accord Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Accord Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Accord Pharmaceuticals Finasteride Products Offered
11.8.5 Accord Pharmaceuticals Recent Development
11.9 Henan Topfond
11.9.1 Henan Topfond Corporation Information
11.9.2 Henan Topfond Description, Business Overview and Total Revenue
11.9.3 Henan Topfond Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Henan Topfond Finasteride Products Offered
11.9.5 Henan Topfond Recent Development
11.10 Zhejiang CONBA Pharmaceutical
11.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
11.10.2 Zhejiang CONBA Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Zhejiang CONBA Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Products Offered
11.10.5 Zhejiang CONBA Pharmaceutical Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Finasteride Products Offered
11.1.5 Merck Recent Development
11.12 Guangdong Eashu Pharmacetical
11.12.1 Guangdong Eashu Pharmacetical Corporation Information
11.12.2 Guangdong Eashu Pharmacetical Description, Business Overview and Total Revenue
11.12.3 Guangdong Eashu Pharmacetical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Guangdong Eashu Pharmacetical Products Offered
11.12.5 Guangdong Eashu Pharmacetical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Finasteride Market Estimates and Projections by Region
12.1.1 Global Finasteride Sales Forecast by Regions 2021-2026
12.1.2 Global Finasteride Revenue Forecast by Regions 2021-2026
12.2 North America Finasteride Market Size Forecast (2021-2026)
12.2.1 North America: Finasteride Sales Forecast (2021-2026)
12.2.2 North America: Finasteride Revenue Forecast (2021-2026)
12.2.3 North America: Finasteride Market Size Forecast by Country (2021-2026)
12.3 Europe Finasteride Market Size Forecast (2021-2026)
12.3.1 Europe: Finasteride Sales Forecast (2021-2026)
12.3.2 Europe: Finasteride Revenue Forecast (2021-2026)
12.3.3 Europe: Finasteride Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Finasteride Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Finasteride Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Finasteride Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Finasteride Market Size Forecast by Region (2021-2026)
12.5 Latin America Finasteride Market Size Forecast (2021-2026)
12.5.1 Latin America: Finasteride Sales Forecast (2021-2026)
12.5.2 Latin America: Finasteride Revenue Forecast (2021-2026)
12.5.3 Latin America: Finasteride Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Finasteride Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Finasteride Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Finasteride Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Finasteride Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Finasteride Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Finasteride Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Finasteride Product Introduction
1.2 Market Segments
1.3 Key Finasteride Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Finasteride Market Size Growth Rate by Type
1.4.2 1mg Tablet
1.4.3 5mg Tablet
1.5 Market by Application
1.5.1 Global Finasteride Market Size Growth Rate by Application
1.5.2 Medical Uses
1.5.3 Application
1.6 Coronavirus Disease 2019 (Covid-19): Finasteride Industry Impact
1.6.1 How the Covid-19 is Affecting the Finasteride Industry
1.6.1.1 Finasteride Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Finasteride Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Finasteride Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Finasteride Market Size Estimates and Forecasts
2.1.1 Global Finasteride Revenue 2015-2026
2.1.2 Global Finasteride Sales 2015-2026
2.2 Finasteride Market Size by Region: 2020 Versus 2026
2.2.1 Global Finasteride Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Finasteride Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL FINASTERIDE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Finasteride Sales by Manufacturers
3.1.1 Finasteride Sales by Manufacturers (2015-2020)
3.1.2 Finasteride Sales Market Share by Manufacturers (2015-2020)
3.2 Finasteride Revenue by Manufacturers
3.2.1 Finasteride Revenue by Manufacturers (2015-2020)
3.2.2 Finasteride Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Finasteride Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Finasteride Revenue in 2019
3.2.5 Global Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Finasteride Price by Manufacturers
3.4 Finasteride Manufacturing Base Distribution, Product Types
3.4.1 Finasteride Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Finasteride Product Type
3.4.3 Date of International Manufacturers Enter into Finasteride Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Finasteride Market Size by Type (2015-2020)
4.1.1 Global Finasteride Sales by Type (2015-2020)
4.1.2 Global Finasteride Revenue by Type (2015-2020)
4.1.3 Finasteride Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Finasteride Market Size Forecast by Type (2021-2026)
4.2.1 Global Finasteride Sales Forecast by Type (2021-2026)
4.2.2 Global Finasteride Revenue Forecast by Type (2021-2026)
4.2.3 Finasteride Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Finasteride Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Finasteride Market Size by Application (2015-2020)
5.1.1 Global Finasteride Sales by Application (2015-2020)
5.1.2 Global Finasteride Revenue by Application (2015-2020)
5.1.3 Finasteride Price by Application (2015-2020)
5.2 Finasteride Market Size Forecast by Application (2021-2026)
5.2.1 Global Finasteride Sales Forecast by Application (2021-2026)
5.2.2 Global Finasteride Revenue Forecast by Application (2021-2026)
5.2.3 Global Finasteride Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Finasteride by Country
6.1.1 North America Finasteride Sales by Country
6.1.2 North America Finasteride Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Finasteride Market Facts & Figures by Type
6.3 North America Finasteride Market Facts & Figures by Application
7 EUROPE
7.1 Europe Finasteride by Country
7.1.1 Europe Finasteride Sales by Country
7.1.2 Europe Finasteride Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Finasteride Market Facts & Figures by Type
7.3 Europe Finasteride Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Finasteride by Region
8.1.1 Asia Pacific Finasteride Sales by Region
8.1.2 Asia Pacific Finasteride Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Finasteride Market Facts & Figures by Type
8.3 Asia Pacific Finasteride Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Finasteride by Country
9.1.1 Latin America Finasteride Sales by Country
9.1.2 Latin America Finasteride Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Finasteride Market Facts & Figures by Type
9.3 Central & South America Finasteride Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Finasteride by Country
10.1.1 Middle East and Africa Finasteride Sales by Country
10.1.2 Middle East and Africa Finasteride Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Finasteride Market Facts & Figures by Type
10.3 Middle East and Africa Finasteride Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Finasteride Products Offered
11.1.5 Merck Recent Development
11.2 Actavis
11.2.1 Actavis Corporation Information
11.2.2 Actavis Description, Business Overview and Total Revenue
11.2.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Actavis Finasteride Products Offered
11.2.5 Actavis Recent Development
11.3 Sandoz
11.3.1 Sandoz Corporation Information
11.3.2 Sandoz Description, Business Overview and Total Revenue
11.3.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sandoz Finasteride Products Offered
11.3.5 Sandoz Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Corporation Information
11.4.2 Teva Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Pharmaceuticals Finasteride Products Offered
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description, Business Overview and Total Revenue
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Finasteride Products Offered
11.5.5 Cipla Recent Development
11.6 RelonChem
11.6.1 RelonChem Corporation Information
11.6.2 RelonChem Description, Business Overview and Total Revenue
11.6.3 RelonChem Sales, Revenue and Gross Margin (2015-2020)
11.6.4 RelonChem Finasteride Products Offered
11.6.5 RelonChem Recent Development
11.7 Dr. Reddy
11.7.1 Dr. Reddy Corporation Information
11.7.2 Dr. Reddy Description, Business Overview and Total Revenue
11.7.3 Dr. Reddy Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy Finasteride Products Offered
11.7.5 Dr. Reddy Recent Development
11.8 Accord Pharmaceuticals
11.8.1 Accord Pharmaceuticals Corporation Information
11.8.2 Accord Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Accord Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Accord Pharmaceuticals Finasteride Products Offered
11.8.5 Accord Pharmaceuticals Recent Development
11.9 Henan Topfond
11.9.1 Henan Topfond Corporation Information
11.9.2 Henan Topfond Description, Business Overview and Total Revenue
11.9.3 Henan Topfond Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Henan Topfond Finasteride Products Offered
11.9.5 Henan Topfond Recent Development
11.10 Zhejiang CONBA Pharmaceutical
11.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
11.10.2 Zhejiang CONBA Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Zhejiang CONBA Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Products Offered
11.10.5 Zhejiang CONBA Pharmaceutical Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Finasteride Products Offered
11.1.5 Merck Recent Development
11.12 Guangdong Eashu Pharmacetical
11.12.1 Guangdong Eashu Pharmacetical Corporation Information
11.12.2 Guangdong Eashu Pharmacetical Description, Business Overview and Total Revenue
11.12.3 Guangdong Eashu Pharmacetical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Guangdong Eashu Pharmacetical Products Offered
11.12.5 Guangdong Eashu Pharmacetical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Finasteride Market Estimates and Projections by Region
12.1.1 Global Finasteride Sales Forecast by Regions 2021-2026
12.1.2 Global Finasteride Revenue Forecast by Regions 2021-2026
12.2 North America Finasteride Market Size Forecast (2021-2026)
12.2.1 North America: Finasteride Sales Forecast (2021-2026)
12.2.2 North America: Finasteride Revenue Forecast (2021-2026)
12.2.3 North America: Finasteride Market Size Forecast by Country (2021-2026)
12.3 Europe Finasteride Market Size Forecast (2021-2026)
12.3.1 Europe: Finasteride Sales Forecast (2021-2026)
12.3.2 Europe: Finasteride Revenue Forecast (2021-2026)
12.3.3 Europe: Finasteride Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Finasteride Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Finasteride Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Finasteride Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Finasteride Market Size Forecast by Region (2021-2026)
12.5 Latin America Finasteride Market Size Forecast (2021-2026)
12.5.1 Latin America: Finasteride Sales Forecast (2021-2026)
12.5.2 Latin America: Finasteride Revenue Forecast (2021-2026)
12.5.3 Latin America: Finasteride Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Finasteride Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Finasteride Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Finasteride Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Finasteride Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Finasteride Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Finasteride Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Finasteride Market Segments
Table 2. Ranking of Global Top Finasteride Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Finasteride Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 1mg Tablet
Table 5. Major Manufacturers of 5mg Tablet
Table 6. COVID-19 Impact Global Market: (Four Finasteride Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Finasteride Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Finasteride Players to Combat Covid-19 Impact
Table 11. Global Finasteride Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Finasteride Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Finasteride Sales by Regions 2015-2020 (MT)
Table 14. Global Finasteride Sales Market Share by Regions (2015-2020)
Table 15. Global Finasteride Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Finasteride Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Finasteride Sales Share by Manufacturers (2015-2020)
Table 18. Global Finasteride Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Finasteride by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Finasteride as of 2019)
Table 20. Finasteride Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Finasteride Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Finasteride Price (2015-2020) (USD/Kg)
Table 23. Finasteride Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Finasteride Product Type
Table 25. Date of International Manufacturers Enter into Finasteride Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Finasteride Sales by Type (2015-2020) (MT)
Table 28. Global Finasteride Sales Share by Type (2015-2020)
Table 29. Global Finasteride Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Finasteride Revenue Share by Type (2015-2020)
Table 31. Finasteride Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 32. Global Finasteride Sales by Application (2015-2020) (MT)
Table 33. Global Finasteride Sales Share by Application (2015-2020)
Table 34. North America Finasteride Sales by Country (2015-2020) (MT)
Table 35. North America Finasteride Sales Market Share by Country (2015-2020)
Table 36. North America Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Finasteride Revenue Market Share by Country (2015-2020)
Table 38. North America Finasteride Sales by Type (2015-2020) (MT)
Table 39. North America Finasteride Sales Market Share by Type (2015-2020)
Table 40. North America Finasteride Sales by Application (2015-2020) (MT)
Table 41. North America Finasteride Sales Market Share by Application (2015-2020)
Table 42. Europe Finasteride Sales by Country (2015-2020) (MT)
Table 43. Europe Finasteride Sales Market Share by Country (2015-2020)
Table 44. Europe Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Finasteride Revenue Market Share by Country (2015-2020)
Table 46. Europe Finasteride Sales by Type (2015-2020) (MT)
Table 47. Europe Finasteride Sales Market Share by Type (2015-2020)
Table 48. Europe Finasteride Sales by Application (2015-2020) (MT)
Table 49. Europe Finasteride Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Finasteride Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Finasteride Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Finasteride Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Finasteride Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Finasteride Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Finasteride Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Finasteride Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Finasteride Sales Market Share by Application (2015-2020)
Table 58. Latin America Finasteride Sales by Country (2015-2020) (MT)
Table 59. Latin America Finasteride Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Finasteride Revenue Market Share by Country (2015-2020)
Table 62. Latin America Finasteride Sales by Type (2015-2020) (MT)
Table 63. Latin America Finasteride Sales Market Share by Type (2015-2020)
Table 64. Latin America Finasteride Sales by Application (2015-2020) (MT)
Table 65. Latin America Finasteride Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Finasteride Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Finasteride Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Finasteride Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Finasteride Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Finasteride Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Finasteride Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Finasteride Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Actavis Corporation Information
Table 80. Actavis Description and Major Businesses
Table 81. Actavis Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Actavis Product
Table 83. Actavis Recent Development
Table 84. Sandoz Corporation Information
Table 85. Sandoz Description and Major Businesses
Table 86. Sandoz Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Sandoz Product
Table 88. Sandoz Recent Development
Table 89. Teva Pharmaceuticals Corporation Information
Table 90. Teva Pharmaceuticals Description and Major Businesses
Table 91. Teva Pharmaceuticals Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Teva Pharmaceuticals Product
Table 93. Teva Pharmaceuticals Recent Development
Table 94. Cipla Corporation Information
Table 95. Cipla Description and Major Businesses
Table 96. Cipla Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Cipla Product
Table 98. Cipla Recent Development
Table 99. RelonChem Corporation Information
Table 100. RelonChem Description and Major Businesses
Table 101. RelonChem Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. RelonChem Product
Table 103. RelonChem Recent Development
Table 104. Dr. Reddy Corporation Information
Table 105. Dr. Reddy Description and Major Businesses
Table 106. Dr. Reddy Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Dr. Reddy Product
Table 108. Dr. Reddy Recent Development
Table 109. Accord Pharmaceuticals Corporation Information
Table 110. Accord Pharmaceuticals Description and Major Businesses
Table 111. Accord Pharmaceuticals Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Accord Pharmaceuticals Product
Table 113. Accord Pharmaceuticals Recent Development
Table 114. Henan Topfond Corporation Information
Table 115. Henan Topfond Description and Major Businesses
Table 116. Henan Topfond Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Henan Topfond Product
Table 118. Henan Topfond Recent Development
Table 119. Zhejiang CONBA Pharmaceutical Corporation Information
Table 120. Zhejiang CONBA Pharmaceutical Description and Major Businesses
Table 121. Zhejiang CONBA Pharmaceutical Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Zhejiang CONBA Pharmaceutical Product
Table 123. Zhejiang CONBA Pharmaceutical Recent Development
Table 124. Shandong Renhetang Pharmaceutical Corporation Information
Table 125. Shandong Renhetang Pharmaceutical Description and Major Businesses
Table 126. Shandong Renhetang Pharmaceutical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Shandong Renhetang Pharmaceutical Product
Table 128. Shandong Renhetang Pharmaceutical Recent Development
Table 129. Guangdong Eashu Pharmacetical Corporation Information
Table 130. Guangdong Eashu Pharmacetical Description and Major Businesses
Table 131. Guangdong Eashu Pharmacetical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Guangdong Eashu Pharmacetical Product
Table 133. Guangdong Eashu Pharmacetical Recent Development
Table 134. Global Finasteride Sales Forecast by Regions (2021-2026) (MT)
Table 135. Global Finasteride Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Finasteride Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Finasteride Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 139. North America: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 141. Europe: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Finasteride Sales Forecast by Region (2021-2026) (MT)
Table 143. Asia Pacific: Finasteride Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 145. Latin America: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 147. Middle East and Africa: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Finasteride Players
Table 152. Finasteride Customers List
Table 153. Finasteride Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 1. Finasteride Market Segments
Table 2. Ranking of Global Top Finasteride Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Finasteride Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 1mg Tablet
Table 5. Major Manufacturers of 5mg Tablet
Table 6. COVID-19 Impact Global Market: (Four Finasteride Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Finasteride Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Finasteride Players to Combat Covid-19 Impact
Table 11. Global Finasteride Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Finasteride Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Finasteride Sales by Regions 2015-2020 (MT)
Table 14. Global Finasteride Sales Market Share by Regions (2015-2020)
Table 15. Global Finasteride Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Finasteride Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Finasteride Sales Share by Manufacturers (2015-2020)
Table 18. Global Finasteride Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Finasteride by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Finasteride as of 2019)
Table 20. Finasteride Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Finasteride Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Finasteride Price (2015-2020) (USD/Kg)
Table 23. Finasteride Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Finasteride Product Type
Table 25. Date of International Manufacturers Enter into Finasteride Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Finasteride Sales by Type (2015-2020) (MT)
Table 28. Global Finasteride Sales Share by Type (2015-2020)
Table 29. Global Finasteride Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Finasteride Revenue Share by Type (2015-2020)
Table 31. Finasteride Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 32. Global Finasteride Sales by Application (2015-2020) (MT)
Table 33. Global Finasteride Sales Share by Application (2015-2020)
Table 34. North America Finasteride Sales by Country (2015-2020) (MT)
Table 35. North America Finasteride Sales Market Share by Country (2015-2020)
Table 36. North America Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Finasteride Revenue Market Share by Country (2015-2020)
Table 38. North America Finasteride Sales by Type (2015-2020) (MT)
Table 39. North America Finasteride Sales Market Share by Type (2015-2020)
Table 40. North America Finasteride Sales by Application (2015-2020) (MT)
Table 41. North America Finasteride Sales Market Share by Application (2015-2020)
Table 42. Europe Finasteride Sales by Country (2015-2020) (MT)
Table 43. Europe Finasteride Sales Market Share by Country (2015-2020)
Table 44. Europe Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Finasteride Revenue Market Share by Country (2015-2020)
Table 46. Europe Finasteride Sales by Type (2015-2020) (MT)
Table 47. Europe Finasteride Sales Market Share by Type (2015-2020)
Table 48. Europe Finasteride Sales by Application (2015-2020) (MT)
Table 49. Europe Finasteride Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Finasteride Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Finasteride Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Finasteride Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Finasteride Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Finasteride Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Finasteride Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Finasteride Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Finasteride Sales Market Share by Application (2015-2020)
Table 58. Latin America Finasteride Sales by Country (2015-2020) (MT)
Table 59. Latin America Finasteride Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Finasteride Revenue Market Share by Country (2015-2020)
Table 62. Latin America Finasteride Sales by Type (2015-2020) (MT)
Table 63. Latin America Finasteride Sales Market Share by Type (2015-2020)
Table 64. Latin America Finasteride Sales by Application (2015-2020) (MT)
Table 65. Latin America Finasteride Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Finasteride Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Finasteride Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Finasteride Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Finasteride Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Finasteride Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Finasteride Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Finasteride Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Finasteride Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Actavis Corporation Information
Table 80. Actavis Description and Major Businesses
Table 81. Actavis Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Actavis Product
Table 83. Actavis Recent Development
Table 84. Sandoz Corporation Information
Table 85. Sandoz Description and Major Businesses
Table 86. Sandoz Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Sandoz Product
Table 88. Sandoz Recent Development
Table 89. Teva Pharmaceuticals Corporation Information
Table 90. Teva Pharmaceuticals Description and Major Businesses
Table 91. Teva Pharmaceuticals Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Teva Pharmaceuticals Product
Table 93. Teva Pharmaceuticals Recent Development
Table 94. Cipla Corporation Information
Table 95. Cipla Description and Major Businesses
Table 96. Cipla Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Cipla Product
Table 98. Cipla Recent Development
Table 99. RelonChem Corporation Information
Table 100. RelonChem Description and Major Businesses
Table 101. RelonChem Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. RelonChem Product
Table 103. RelonChem Recent Development
Table 104. Dr. Reddy Corporation Information
Table 105. Dr. Reddy Description and Major Businesses
Table 106. Dr. Reddy Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Dr. Reddy Product
Table 108. Dr. Reddy Recent Development
Table 109. Accord Pharmaceuticals Corporation Information
Table 110. Accord Pharmaceuticals Description and Major Businesses
Table 111. Accord Pharmaceuticals Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Accord Pharmaceuticals Product
Table 113. Accord Pharmaceuticals Recent Development
Table 114. Henan Topfond Corporation Information
Table 115. Henan Topfond Description and Major Businesses
Table 116. Henan Topfond Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Henan Topfond Product
Table 118. Henan Topfond Recent Development
Table 119. Zhejiang CONBA Pharmaceutical Corporation Information
Table 120. Zhejiang CONBA Pharmaceutical Description and Major Businesses
Table 121. Zhejiang CONBA Pharmaceutical Finasteride Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Zhejiang CONBA Pharmaceutical Product
Table 123. Zhejiang CONBA Pharmaceutical Recent Development
Table 124. Shandong Renhetang Pharmaceutical Corporation Information
Table 125. Shandong Renhetang Pharmaceutical Description and Major Businesses
Table 126. Shandong Renhetang Pharmaceutical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Shandong Renhetang Pharmaceutical Product
Table 128. Shandong Renhetang Pharmaceutical Recent Development
Table 129. Guangdong Eashu Pharmacetical Corporation Information
Table 130. Guangdong Eashu Pharmacetical Description and Major Businesses
Table 131. Guangdong Eashu Pharmacetical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Guangdong Eashu Pharmacetical Product
Table 133. Guangdong Eashu Pharmacetical Recent Development
Table 134. Global Finasteride Sales Forecast by Regions (2021-2026) (MT)
Table 135. Global Finasteride Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Finasteride Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Finasteride Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 139. North America: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 141. Europe: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Finasteride Sales Forecast by Region (2021-2026) (MT)
Table 143. Asia Pacific: Finasteride Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 145. Latin America: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Finasteride Sales Forecast by Country (2021-2026) (MT)
Table 147. Middle East and Africa: Finasteride Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Finasteride Players
Table 152. Finasteride Customers List
Table 153. Finasteride Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Finasteride Product Picture
Figure 2. Global Finasteride Sales Market Share by Type in 2020 & 2026
Figure 3. 1mg Tablet Product Picture
Figure 4. 5mg Tablet Product Picture
Figure 5. Global Finasteride Sales Market Share by Application in 2020 & 2026
Figure 6. Medical Uses
Figure 7. Application 2
Figure 8. Finasteride Report Years Considered
Figure 9. Global Finasteride Market Size 2015-2026 (US$ Million)
Figure 10. Global Finasteride Sales 2015-2026 (MT)
Figure 11. Global Finasteride Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Finasteride Sales Market Share by Region (2015-2020)
Figure 13. Global Finasteride Sales Market Share by Region in 2019
Figure 14. Global Finasteride Revenue Market Share by Region (2015-2020)
Figure 15. Global Finasteride Revenue Market Share by Region in 2019
Figure 16. Global Finasteride Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Finasteride Revenue in 2019
Figure 18. Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Finasteride Sales Market Share by Type (2015-2020)
Figure 20. Global Finasteride Sales Market Share by Type in 2019
Figure 21. Global Finasteride Revenue Market Share by Type (2015-2020)
Figure 22. Global Finasteride Revenue Market Share by Type in 2019
Figure 23. Global Finasteride Market Share by Price Range (2015-2020)
Figure 24. Global Finasteride Sales Market Share by Application (2015-2020)
Figure 25. Global Finasteride Sales Market Share by Application in 2019
Figure 26. Global Finasteride Revenue Market Share by Application (2015-2020)
Figure 27. Global Finasteride Revenue Market Share by Application in 2019
Figure 28. North America Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 29. North America Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Finasteride Sales Market Share by Country in 2019
Figure 31. North America Finasteride Revenue Market Share by Country in 2019
Figure 32. U.S. Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 33. U.S. Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 35. Canada Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Finasteride Market Share by Type in 2019
Figure 37. North America Finasteride Market Share by Application in 2019
Figure 38. Europe Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 39. Europe Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Finasteride Sales Market Share by Country in 2019
Figure 41. Europe Finasteride Revenue Market Share by Country in 2019
Figure 42. Germany Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 43. Germany Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 45. France Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 47. U.K. Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 49. Italy Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 51. Russia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Finasteride Market Share by Type in 2019
Figure 53. Europe Finasteride Market Share by Application in 2019
Figure 54. Asia Pacific Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 55. Asia Pacific Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Finasteride Sales Market Share by Region in 2019
Figure 57. Asia Pacific Finasteride Revenue Market Share by Region in 2019
Figure 58. China Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 59. China Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 61. Japan Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 63. South Korea Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 65. India Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 67. Australia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 69. Taiwan Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 71. Indonesia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 73. Thailand Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 75. Malaysia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 77. Philippines Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 79. Vietnam Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Finasteride Market Share by Type in 2019
Figure 81. Asia Pacific Finasteride Market Share by Application in 2019
Figure 82. Latin America Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 83. Latin America Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Finasteride Sales Market Share by Country in 2019
Figure 85. Latin America Finasteride Revenue Market Share by Country in 2019
Figure 86. Mexico Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 87. Mexico Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 89. Brazil Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 91. Argentina Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Finasteride Market Share by Type in 2019
Figure 93. Latin America Finasteride Market Share by Application in 2019
Figure 94. Middle East and Africa Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 95. Middle East and Africa Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Finasteride Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Finasteride Revenue Market Share by Country in 2019
Figure 98. Turkey Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 99. Turkey Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 101. Saudi Arabia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 103. U.A.E Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Finasteride Market Share by Type in 2019
Figure 105. Middle East and Africa Finasteride Market Share by Application in 2019
Figure 106. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. RelonChem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dr. Reddy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Accord Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Henan Topfond Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zhejiang CONBA Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Shandong Renhetang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Guangdong Eashu Pharmacetical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. North America Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Europe Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Asia Pacific Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Latin America Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. Middle East and Africa Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
Figure 1. Finasteride Product Picture
Figure 2. Global Finasteride Sales Market Share by Type in 2020 & 2026
Figure 3. 1mg Tablet Product Picture
Figure 4. 5mg Tablet Product Picture
Figure 5. Global Finasteride Sales Market Share by Application in 2020 & 2026
Figure 6. Medical Uses
Figure 7. Application 2
Figure 8. Finasteride Report Years Considered
Figure 9. Global Finasteride Market Size 2015-2026 (US$ Million)
Figure 10. Global Finasteride Sales 2015-2026 (MT)
Figure 11. Global Finasteride Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Finasteride Sales Market Share by Region (2015-2020)
Figure 13. Global Finasteride Sales Market Share by Region in 2019
Figure 14. Global Finasteride Revenue Market Share by Region (2015-2020)
Figure 15. Global Finasteride Revenue Market Share by Region in 2019
Figure 16. Global Finasteride Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Finasteride Revenue in 2019
Figure 18. Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Finasteride Sales Market Share by Type (2015-2020)
Figure 20. Global Finasteride Sales Market Share by Type in 2019
Figure 21. Global Finasteride Revenue Market Share by Type (2015-2020)
Figure 22. Global Finasteride Revenue Market Share by Type in 2019
Figure 23. Global Finasteride Market Share by Price Range (2015-2020)
Figure 24. Global Finasteride Sales Market Share by Application (2015-2020)
Figure 25. Global Finasteride Sales Market Share by Application in 2019
Figure 26. Global Finasteride Revenue Market Share by Application (2015-2020)
Figure 27. Global Finasteride Revenue Market Share by Application in 2019
Figure 28. North America Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 29. North America Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Finasteride Sales Market Share by Country in 2019
Figure 31. North America Finasteride Revenue Market Share by Country in 2019
Figure 32. U.S. Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 33. U.S. Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 35. Canada Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Finasteride Market Share by Type in 2019
Figure 37. North America Finasteride Market Share by Application in 2019
Figure 38. Europe Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 39. Europe Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Finasteride Sales Market Share by Country in 2019
Figure 41. Europe Finasteride Revenue Market Share by Country in 2019
Figure 42. Germany Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 43. Germany Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 45. France Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 47. U.K. Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 49. Italy Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 51. Russia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Finasteride Market Share by Type in 2019
Figure 53. Europe Finasteride Market Share by Application in 2019
Figure 54. Asia Pacific Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 55. Asia Pacific Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Finasteride Sales Market Share by Region in 2019
Figure 57. Asia Pacific Finasteride Revenue Market Share by Region in 2019
Figure 58. China Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 59. China Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 61. Japan Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 63. South Korea Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 65. India Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 67. Australia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 69. Taiwan Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 71. Indonesia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 73. Thailand Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 75. Malaysia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 77. Philippines Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 79. Vietnam Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Finasteride Market Share by Type in 2019
Figure 81. Asia Pacific Finasteride Market Share by Application in 2019
Figure 82. Latin America Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 83. Latin America Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Finasteride Sales Market Share by Country in 2019
Figure 85. Latin America Finasteride Revenue Market Share by Country in 2019
Figure 86. Mexico Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 87. Mexico Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 89. Brazil Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 91. Argentina Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Finasteride Market Share by Type in 2019
Figure 93. Latin America Finasteride Market Share by Application in 2019
Figure 94. Middle East and Africa Finasteride Sales Growth Rate 2015-2020 (MT)
Figure 95. Middle East and Africa Finasteride Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Finasteride Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Finasteride Revenue Market Share by Country in 2019
Figure 98. Turkey Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 99. Turkey Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 101. Saudi Arabia Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Finasteride Sales Growth Rate (2015-2020) (MT)
Figure 103. U.A.E Finasteride Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Finasteride Market Share by Type in 2019
Figure 105. Middle East and Africa Finasteride Market Share by Application in 2019
Figure 106. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. RelonChem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dr. Reddy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Accord Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Henan Topfond Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zhejiang CONBA Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Shandong Renhetang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Guangdong Eashu Pharmacetical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. North America Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Europe Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Asia Pacific Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Latin America Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Finasteride Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. Middle East and Africa Finasteride Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
